evolcSign inStart free
Menu

Aboleris Pharma

Develops immune-tolerance therapies for patients with autoimmune diseases and organ transplant rejection

Nantes, FranceFounded 2019aboleris-pharma.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

About Aboleris Pharma

Aboleris Pharma is a clinical-stage biopharmaceutical company developing therapies that aim to restore immune tolerance. Its lead program, ABO21009, is an anti-CD45RC antibody in Phase 1, targeting pathogenic effector T and B cells while preserving regulatory cells and immune memory.

Its therapies target autoimmune, inflammatory and degenerative diseases, as well as organ transplant rejection. The lead program is being developed for conditions including rheumatoid arthritis, inflammatory bowel disease and organ transplantation.

The company was founded in 2019 and is headquartered in Nantes, France. It was founded by scientists Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert.

Product: Develops antibody-based immune-tolerance therapies, including the Phase 1 lead program ABO21009 targeting CD45RC.

Jobs at Aboleris Pharma

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Acticor Biotech

    Clinical-stage biopharma developing glenzocimab, an antithrombotic antibody fragment for acute ischemic stroke patients
    Paris, FranceBiotech & pharmaFounded 20131 open job
    New on Evolc

  • Activ-H

    Superacid flow chemistry R&D services for pharmaceutical and biotech drug discovery teams
    Poitiers, FranceBiotech & pharmaFounded 20231 open job
    Young companyNew on Evolc

  • Adcytherix

    Develops antibody-drug conjugate cancer therapies for patients with cancers resistant to current treatments
    Marseille, FranceBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Ademtech

    Magnetic particles and molecular diagnostic kits for IVD, life sciences and forensic laboratories
    Merignac, FranceBiotech & pharmaFounded 2000

  • Adhexpharma

    Develops and manufactures pharmaceutical patches and oral films for pharmaceutical and biotechnology companies
    Paris, FranceBiotech & pharmaFounded 2007

  • Adipopharma

    Develops peptide therapeutics targeting insulin resistance and type 2 diabetes for patients with metabolic disease
    Strasbourg, FranceBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Backend

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.